Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × naldemedine × Other × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Opioid-Induced Constipation 3 Vomiting 1 Neoplasms 1 Nausea 1 Constipation 1

Interventions

naloxegol 3 Surveys and Questionnaires 3 Resistance Training 3 Nutrition Assessment 3 Exercise 3 alvimopan 2 Therapeutics 2 Psychiatric Rehabilitation 2 Oxygen 2 Nutritional Status 2 Mouthwashes 2 Morphine 2 Interviews as Topic 2 Counseling 2 semaglutide 1 naldemedine 1 methylnaltrexone 1 kang-lai-te 1 hydrated silica gel-based toothpaste 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 calcium phosphate 1 auricularum 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Weights and Measures 1 Walking 1 Urine Specimen Collection 1 Toothbrushing 1 Standard of Care 1 Spermine Synthase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07231796 2026-01-02

NOCON

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Opioid-Induced Constipation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡